Advertisement
Screener

Savara Inc (SVRA) Operating Cash Flow

2.8 / 5 stars · 68/120 Roast Me

Savara Inc Operating Cash Flow

Savara Inc (SVRA) reported Operating Cash Flow of -$62.79 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.

Financial Statements › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-11

  • Savara Inc net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$29.75M.
  • Savara Inc net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$33.05M.
  • Savara Inc net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$25.06M.
  • Savara Inc net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$22.53M.
  • Savara Inc net cash provided by (used in) operating activities for fiscal 2025 was -$101.04M.
  • Savara Inc net cash provided by (used in) operating activities for fiscal 2024 was -$89.09M.
  • Savara Inc net cash provided by (used in) operating activities for fiscal 2023 was -$51.06M.
  • Savara Inc net cash provided by (used in) operating activities for fiscal 2022 was -$34.55M.
Period endNet Cash Provided by (Used in) Operating Activities 3 monthNet Cash Provided by (Used in) Operating Activities 3 month as first filedNet Cash Provided by (Used in) Operating Activities 6 monthNet Cash Provided by (Used in) Operating Activities 6 month as first filedNet Cash Provided by (Used in) Operating Activities 9 monthNet Cash Provided by (Used in) Operating Activities 9 month as first filedNet Cash Provided by (Used in) Operating Activities 12 monthNet Cash Provided by (Used in) Operating Activities 181 monthNet Cash Provided by (Used in) Operating Activities 184 monthNet Cash Provided by (Used in) Operating Activities 187 monthNet Cash Provided by (Used in) Operating Activities 190 monthNet Cash Provided by (Used in) Operating Activities 193 monthNet Cash Provided by (Used in) Operating Activities 196 monthNet Cash Provided by (Used in) Operating Activities 199 monthNet Cash Provided by (Used in) Operating Activities 202 monthNet Cash Provided by (Used in) Operating Activities 205 monthNet Cash Provided by (Used in) Operating Activities 208 monthNet Cash Provided by (Used in) Operating Activities 211 monthNet Cash Provided by (Used in) Operating Activities 214 month
2026-06-30-$29.75M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11
-$62.79M
10-Q · filed 2026-08-11
-$87.85M
derived: sum of 3 quarters · filed 2026-08-11
-$110.38M
derived: sum of 4 quarters · filed 2026-08-11
2026-03-31-$33.05M
10-Q · filed 2026-05-12
-$58.10M
derived: sum of 2 quarters · filed 2026-05-12
-$80.63M
derived: sum of 3 quarters · filed 2026-05-12
-$106.89M
derived: sum of 4 quarters · filed 2026-08-11
2025-12-31-$25.06M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13
-$47.59M
derived: sum of 2 quarters · filed 2026-03-13
-$73.85M
derived: sum of 3 quarters · filed 2026-08-11
-$101.04M
10-K · filed 2026-03-13
2025-09-30-$22.53M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12
-$48.79M
derived: sum of 2 quarters · filed 2026-08-11
-$75.98M
10-Q · filed 2025-11-12
-$99.26M
derived: sum of 4 quarters · filed 2026-08-11
2025-06-30-$26.26M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11
-$53.45M
10-Q · filed 2026-08-11
-$76.73M
derived: sum of 3 quarters · filed 2026-08-11
-$99.40M
derived: sum of 4 quarters · filed 2026-08-11
2025-03-31-$27.19M
10-Q · filed 2026-05-12
-$50.47M
derived: sum of 2 quarters · filed 2026-05-12
-$73.14M
derived: sum of 3 quarters · filed 2026-05-12
-$95.63M
derived: sum of 4 quarters · filed 2026-05-12
2024-12-31-$23.28M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13
-$45.95M
derived: sum of 2 quarters · filed 2026-03-13
-$68.44M
derived: sum of 3 quarters · filed 2026-03-13
-$89.09M
10-K · filed 2026-03-13
2024-09-30-$22.67M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12
-$45.16M
derived: sum of 2 quarters · filed 2025-11-12
-$65.81M
10-Q · filed 2025-11-12
-$81.41M
derived: sum of 4 quarters · filed 2025-11-12
2024-06-30-$22.50M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13
-$43.14M
10-Q · filed 2025-08-13
-$58.74M
derived: sum of 3 quarters · filed 2025-08-13
-$71.90M
derived: sum of 4 quarters · filed 2025-08-13
2024-03-31-$20.64M
10-Q · filed 2025-05-13
-$36.25M
derived: sum of 2 quarters · filed 2025-05-13
-$49.41M
derived: sum of 3 quarters · filed 2025-05-13
-$59.68M
derived: sum of 4 quarters · filed 2025-05-13
2023-12-31-$15.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27
-$28.76M
derived: sum of 2 quarters · filed 2025-03-27
-$39.03M
derived: sum of 3 quarters · filed 2025-03-27
-$51.06M
10-K · filed 2025-03-27
2023-09-30-$13.16M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12
-$23.43M
derived: sum of 2 quarters · filed 2024-11-12
-$35.46M
10-Q · filed 2024-11-12
-$44.11M
derived: sum of 4 quarters · filed 2024-11-12
2023-06-30-$10.27M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12
-$22.30M
10-Q · filed 2024-08-12
-$30.95M
derived: sum of 3 quarters · filed 2024-08-12
-$39.11M
derived: sum of 4 quarters · filed 2024-08-12
2023-03-31-$12.03M
10-Q · filed 2024-05-09
-$20.68M
derived: sum of 2 quarters · filed 2024-05-09
-$28.84M
derived: sum of 3 quarters · filed 2024-05-09
-$38.16M
derived: sum of 4 quarters · filed 2024-05-09
2022-12-31-$8.65M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07
-$16.81M
derived: sum of 2 quarters · filed 2024-03-07
-$26.13M
derived: sum of 3 quarters · filed 2024-03-07
-$34.55M
10-K · filed 2024-03-07
2022-09-30-$8.16M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09
-$17.48M
derived: sum of 2 quarters · filed 2023-11-09
-$25.90M
10-Q · filed 2023-11-09
-$35.27M
derived: sum of 4 quarters · filed 2023-11-09
2022-06-30-$9.32M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10
-$17.74M
10-Q · filed 2023-08-10
-$27.10M
derived: sum of 3 quarters · filed 2023-08-10
-$36.03M
derived: sum of 4 quarters · filed 2023-08-10
2022-03-31-$8.43M
10-Q · filed 2023-05-15
-$17.79M
derived: sum of 2 quarters · filed 2023-05-15
-$26.71M
derived: sum of 3 quarters · filed 2023-05-15
-$38.91M
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31-$9.36M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30
-$18.29M
derived: sum of 2 quarters · filed 2023-03-30
-$30.48M
derived: sum of 3 quarters · filed 2023-03-30
-$40.08M
10-K · filed 2023-03-30
2021-09-30-$8.93M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10
-$21.12M
derived: sum of 2 quarters · filed 2022-11-10
-$30.72M
10-Q · filed 2022-11-10
-$43.02M
derived: sum of 4 quarters · filed 2022-11-10
2021-06-30-$12.19M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11
-$21.79M
10-Q · filed 2022-08-11
-$34.09M
derived: sum of 3 quarters · filed 2022-08-11
-$40.80M
derived: sum of 4 quarters · filed 2022-08-11
2021-03-31-$9.60M
10-Q · filed 2022-05-11
-$21.90M
derived: sum of 2 quarters · filed 2022-05-11
-$28.60M
derived: sum of 3 quarters · filed 2022-05-11
-$36.35M
derived: sum of 4 quarters · filed 2022-05-11
2020-12-31-$12.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30
-$19.00M
derived: sum of 2 quarters · filed 2022-03-30
-$26.76M
derived: sum of 3 quarters · filed 2022-03-30
-$39.84M
10-K · filed 2022-03-30
2020-09-30-$6.71M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12
-$14.46M
derived: sum of 2 quarters · filed 2021-11-12
-$27.54M
10-Q · filed 2021-11-12
-$37.48M
derived: sum of 4 quarters · filed 2021-11-12
2020-06-30-$7.75M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12
-$20.83M
10-Q · filed 2021-08-12
-$30.78M
derived: sum of 3 quarters · filed 2021-08-12
-$42.19M
derived: sum of 4 quarters · filed 2021-08-12
2020-03-31-$13.08M
10-Q · filed 2021-05-13
-$23.02M
derived: sum of 2 quarters · filed 2021-05-13
-$34.44M
derived: sum of 3 quarters · filed 2021-05-13
-$47.34M
derived: sum of 4 quarters · filed 2021-05-13
2019-12-31-$9.95M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10
-$21.36M
derived: sum of 2 quarters · filed 2021-03-10
-$34.26M
derived: sum of 3 quarters · filed 2021-03-10
-$45.12M
10-K · filed 2021-03-10
2019-09-30-$11.41M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
-$24.32M
derived: sum of 2 quarters · filed 2020-11-05
-$35.18M
10-Q · filed 2020-11-05
-$45.67M
derived: sum of 4 quarters · filed 2020-11-05
2019-06-30-$12.90M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06
-$23.76M
10-Q · filed 2020-08-06
-$34.26M
derived: sum of 3 quarters · filed 2020-08-06
-$43.02M
derived: sum of 4 quarters · filed 2020-08-06
2019-03-31-$10.86M
10-Q · filed 2020-05-07
-$21.35M
derived: sum of 2 quarters · filed 2020-05-07
-$30.11M
derived: sum of 3 quarters · filed 2020-05-07
-$40.46M
derived: sum of 4 quarters · filed 2020-05-07
2018-12-31-$10.49M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12
-$19.25M
derived: sum of 2 quarters · filed 2020-03-12
-$29.60M
derived: sum of 3 quarters · filed 2020-03-12
-$39.27M
10-K · filed 2020-03-12
2018-09-30-$8.76M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07
-$19.11M
derived: sum of 2 quarters · filed 2019-11-07
-$28.78M
10-Q · filed 2019-11-07
-$38.25M
derived: sum of 4 quarters · filed 2019-11-07
2018-06-30-$10.35M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08
-$20.02M
10-Q · filed 2019-08-08
-$29.49M
derived: sum of 3 quarters · filed 2019-08-08
-$37.74M
derived: sum of 4 quarters · filed 2019-08-08
2018-03-31-$9.67M
10-Q · filed 2019-05-09
-$19.14M
derived: sum of 2 quarters · filed 2019-05-09
-$27.39M
derived: sum of 3 quarters · filed 2019-05-09
2017-12-31-$9.47M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13
-$17.72M
derived: sum of 2 quarters · filed 2019-03-13
-$28.23M
10-K · filed 2019-03-13
2017-09-30-$8.25M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07
-$18.76M
10-Q · filed 2018-11-07
2017-06-30-$10.52M
10-Q · filed 2018-08-09
2014-03-31-$6.27M
10-Q · filed 2014-05-05
-$11.13M
derived: sum of 2 quarters · filed 2014-05-05
-$14.90M
derived: sum of 3 quarters · filed 2014-05-05
-$19.57M
derived: sum of 4 quarters · filed 2014-05-05
-$158.23M
10-Q · filed 2014-05-05
2013-12-31-$4.86M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-26
-$8.63M
derived: sum of 2 quarters · filed 2014-03-26
-$13.30M
derived: sum of 3 quarters · filed 2014-03-26
-$17.79M
10-K · filed 2014-03-26
-$151.96M
10-K · filed 2014-03-26
2013-09-30-$3.77M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-04
-$8.44M
derived: sum of 2 quarters · filed 2013-11-04
-$12.93M
10-Q · filed 2013-11-04
-$16.28M
derived: sum of 4 quarters · filed 2014-05-05
-$147.09M
10-Q · filed 2013-11-04
2013-06-30-$4.67M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-05
-$9.16M
10-Q · filed 2013-08-05
-$12.51M
derived: sum of 3 quarters · filed 2014-05-05
-$15.67M
derived: sum of 4 quarters · filed 2014-05-05
-$143.33M
10-Q · filed 2013-08-05
2013-03-31-$4.49M
10-Q · filed 2014-05-05
-$7.84M
derived: sum of 2 quarters · filed 2014-05-05
-$11.00M
derived: sum of 3 quarters · filed 2014-05-05
-$13.95M
derived: sum of 4 quarters · filed 2014-05-05
-$138.65M
10-Q · filed 2013-05-15
2012-12-31-$3.35M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-26
-$6.51M
derived: sum of 2 quarters · filed 2014-03-26
-$9.46M
derived: sum of 3 quarters · filed 2014-03-26
-$13.92M
10-K · filed 2014-03-26
-$134.17M
10-K · filed 2013-03-19
2012-09-30-$3.17M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-04
-$6.11M
derived: sum of 2 quarters · filed 2013-11-04
-$10.57M
10-Q · filed 2013-11-04
-$13.59M
derived: sum of 4 quarters · filed 2013-11-04
-$130.82M
10-Q · filed 2012-11-05
2012-06-30-$2.94M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-05
-$7.40M
10-Q · filed 2013-08-05
-$7.35M
10-Q · filed 2012-08-06
-$10.42M
derived: sum of 3 quarters · filed 2013-08-05
-$13.89M
derived: sum of 4 quarters · filed 2013-08-05
-$127.60M
10-Q · filed 2012-08-06
2012-03-31-$4.46M
10-Q · filed 2013-05-15
-$4.41M
10-Q · filed 2012-05-07
-$7.48M
derived: sum of 2 quarters · filed 2013-05-15
-$10.95M
derived: sum of 3 quarters · filed 2013-05-15
-$15.54M
derived: sum of 4 quarters · filed 2013-05-15
-$124.66M
10-Q · filed 2012-05-07
2011-12-31-$3.02M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-19
-$6.49M
derived: sum of 2 quarters · filed 2013-03-19
-$11.08M
derived: sum of 3 quarters · filed 2013-03-19
-$13.47M
10-K · filed 2013-03-19
-$120.25M
10-K · filed 2012-03-08
2011-09-30-$3.47M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-05
-$8.07M
derived: sum of 2 quarters · filed 2012-11-05
-$10.45M
10-Q · filed 2012-11-05
-$10.43M
10-Q · filed 2011-11-08
-$11.78M
derived: sum of 4 quarters · filed 2012-11-05
-$117.21M
10-Q · filed 2011-11-08
2011-06-30-$4.59M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-06
-$6.98M
10-Q · filed 2012-08-06
-$8.31M
derived: sum of 3 quarters · filed 2012-08-06
-$10.14M
derived: sum of 4 quarters · filed 2012-08-06
-$113.76M
10-Q · filed 2011-08-08
2011-03-31-$2.38M
10-Q · filed 2012-05-07
-$3.72M
derived: sum of 2 quarters · filed 2012-05-07
-$5.55M
derived: sum of 3 quarters · filed 2012-05-07
2010-12-31-$1.33M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-08
-$3.16M
derived: sum of 2 quarters · filed 2012-03-08
-$8.34M
10-K · filed 2012-03-08
2010-09-30-$1.83M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08
-$7.01M
10-Q · filed 2011-11-08
2010-06-30-$5.18M
10-Q · filed 2011-08-08

Similar stocks

Stock NameCountryMarket CapPE Ratio
MoonLake Immunotherapeutics (MLTX)Switzerland$1.031B-5.43
MANNKIND CORP (MNKD)United States$1.058B-30.41
Alto Neuroscience, Inc. (ANRO)United States$1.065B-11.02
Pacira BioSciences, Inc. (PCRX)United States$1.020B69.03
Janux Therapeutics, Inc. (JANX)United States$1.019B-9.15
Corvus Pharmaceuticals, Inc. (CRVS)United States$0.994B-23.25
Amphastar Pharmaceuticals, Inc. (AMPH)United States$1.116B10.93
Kura Oncology, Inc. (KURA)United States$0.967B-3.29
Arbutus Biopharma Corp (ABUS)$0.965B6.19
Seaport Therapeutics, Inc. (SPTX)United States$1.131B